1. Home
  2. HUIZ vs CLGN Comparison

HUIZ vs CLGN Comparison

Compare HUIZ & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

HOLD

Current Price

$1.70

Market Cap

17.4M

Sector

Finance

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.66

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUIZ
CLGN
Founded
2006
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Specialty Insurers
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
18.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
HUIZ
CLGN
Price
$1.70
$0.66
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$2.30
$11.00
AVG Volume (30 Days)
5.3K
36.5K
Earning Date
03-27-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.67
$1,596.12
Revenue Next Year
$8.55
N/A
P/E Ratio
$7.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.50
52 Week High
$4.16
$4.98

Technical Indicators

Market Signals
Indicator
HUIZ
CLGN
Relative Strength Index (RSI) 43.17 45.41
Support Level $1.60 $0.50
Resistance Level $2.19 $0.73
Average True Range (ATR) 0.11 0.07
MACD 0.01 0.04
Stochastic Oscillator 28.39 30.74

Price Performance

Historical Comparison
HUIZ
CLGN

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: